Clinical Trials Directory

Trials / Completed

CompletedNCT00005119

Altered Calcium and Vitamin D in PMDD or Severe PMS

Altered Calcium And Vitamin D Metabolism in PMDD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Osteoporosis has become one of the most widely recognized disorders of our times affecting an estimated 25 million women in this country. Recent evidence has suggested that premenstrual syndrome (PMS) is associated with a calcium deficiency state and bone loss. This may place premenopausal women at greater risk for osteoporosis. An entity such as PMS may be an important physiological marker of a calcium disturbance. The purpose of this investigation is to understand more completely the extent to which calcium balance is disturbed in severe PMS or Premenstrual Dysphoric Disorder (PMDD) by utilizing new tools to assess calcium and bone turnover. The long term objective is to elucidate the pathophysiology of PMDD or severe PMS as it relates to calcium hormones and bone markers. The experimental design involves the comparison between women witn severe PMS and asymptomatic controls.

Conditions

Interventions

TypeNameDescription
PROCEDUREMeasures of calcium and bone turnover

Timeline

Start date
2000-05-01
Completion
2003-10-01
First posted
2000-04-20
Last updated
2010-03-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00005119. Inclusion in this directory is not an endorsement.